Strong evidence, from decades of treating individuals with inborn errors of B 12 metabolism, supports the safety of parenteral, lifelong, even high dose hydroxocobalamin, sometimes even at very high doses.6768 Long term epidemiological studies also indicate that treatment with pharmacological B 12 doses and the corresponding increase in serum B 12 do not increase mortality.69 Data on the safety of cyanocobalamin, when administered with high frequency (ie, one to two times a week) for a longer period of time, are lacking
Alloubani A, Saleh A, Abdelhafiz I
That table contains the honest picture
Retatrutide (GLP-1/GIP/Glucagon): introduce un tercer eje (glucagn) relacionado con las discusiones sobre el gasto energtico
Methods and results To test this hypothesis, we developed a rat model of hyperlipidemia induced by high-fat diet for 16 weeks, during which rats were treated with 1 mg/kg salvianolic acid A (Sal A) for the final 4 weeks
Self-monitoring: Food logging, activity tracking, and regular weigh-ins remain among the most powerful predictors of weight loss success
